Biolife Solutions (BLFS) EBT (2010 - 2026)

Biolife Solutions (BLFS) has reported EBT for 17 consecutive years, with $2.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBT rose 118.12% year-over-year to $2.8 million in Q2 2026; TTM through Jun 2026 was $8.1 million, a 153.8% increase from a year earlier, with the FY2025 full-year figure at -$12.1 million, down 36.93% from the prior year.
• EBT was $2.8 million for Q2 2026 at Biolife Solutions, up from $1.2 million in the prior quarter.
• Over five years, EBT peaked at $90.7 million in Q4 2022 and troughed at -$76.6 million in Q2 2022.
• A 5-year average of -$2.1 million and a median of -$1.9 million in 2024 frame the typical range for EBT.
• Across the five-year window, EBT sank 1538.52% in 2022 and surged 616.84% in 2025, its largest moves.
• Over 5 years, EBT stood at $90.7 million in 2022, then slumped by 80.58% to $17.6 million in 2023, then slumped by 97.34% to $469000.0 in 2024, then surged by 616.84% to $3.4 million in 2025, then decreased by 18.11% to $2.8 million in 2026.
• The last three EBT figures came in at $2.8 million (Q2 2026), $1.2 million (Q1 2026), and $3.4 million (Q4 2025), per Business Quant data.